2020 COG共识意见：四肢横纹肌肉瘤的手术治疗

2020-08-09 美国儿童肿瘤协作组 Pediatr Blood Cancer . 2020 Aug 9;

2020年8月，美国儿童肿瘤协作组(COG)联合欧洲儿童软组织肉瘤研究组共同发布了四肢横纹肌肉瘤的手术治疗共识。四肢横纹肌肉瘤的治疗仍具挑战，本文主要针对四肢横纹肌肉瘤的手术治疗，包括活检，淋巴结分期

中文标题：

英文标题：

Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft-Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe

发布机构：

美国儿童肿瘤协作组

发布日期：

2020-08-09

简要介绍：

2020年8月，美国儿童肿瘤协作组(COG)联合欧洲儿童软组织肉瘤研究组共同发布了四肢横纹肌肉瘤的手术治疗共识。四肢横纹肌肉瘤的治疗仍具挑战，本文主要针对四肢横纹肌肉瘤的手术治疗，包括活检，淋巴结分期以及治疗时机，复发再切除、重建和手术入路等内容提供指导建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=689fb1c00195217b, title=2020 COG共识意见：四肢横纹肌肉瘤的手术治疗, enTitle=Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft-Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe, guiderFrom=Pediatr Blood Cancer . 2020 Aug 9;, authorId=0, author=, summary=2020年8月，美国儿童肿瘤协作组(COG)联合欧洲儿童软组织肉瘤研究组共同发布了四肢横纹肌肉瘤的手术治疗共识。四肢横纹肌肉瘤的治疗仍具挑战，本文主要针对四肢横纹肌肉瘤的手术治疗，包括活检，淋巴结分期, cover=https://img.medsci.cn/2020813/1597330343793_2020535.jpg, journalId=0, articlesId=null, associationId=1456, associationName=美国儿童肿瘤协作组, associationIntro=, copyright=0, guiderPublishedTime=Sun Aug 09 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，美国儿童肿瘤协作组(COG)联合欧洲儿童软组织肉瘤研究组共同发布了四肢横纹肌肉瘤的手术治疗共识。四肢横纹肌肉瘤的治疗仍具挑战，本文主要针对四肢横纹肌肉瘤的手术治疗，包括活检，淋巴结分期以及治疗时机，复发再切除、重建和手术入路等内容提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=15167, tagName=横纹肌肉瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=15167, guiderKeyword=横纹肌肉瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=5, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3653, appHits=94, showAppHits=0, pcHits=787, showPcHits=3558, likes=0, shares=7, comments=14, approvalStatus=1, publishedTime=Thu Aug 13 23:27:22 CST 2020, publishedTimeString=2020-08-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Aug 13 22:52:31 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:12:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 COG共识意见：四肢横纹肌肉瘤的手术治疗.pdf)])

2020 COG共识意见：四肢横纹肌肉瘤的手术治疗.pdf

下载请点击：

评论区 (10)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1234452, encodeId=5be91234452ca, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:50:09 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234009, encodeId=9777123400906, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbfd8246369, createdName=ms2000000967583627, createdTime=Fri Jul 22 12:54:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234008, encodeId=b23f1234008ad, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbfd8246369, createdName=ms2000000967583627, createdTime=Fri Jul 22 12:54:25 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009151, encodeId=887a1009151d8, content=怎么获得积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82c15576659, createdName=ms4000001580579190, createdTime=Wed Aug 18 15:37:03 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001213, encodeId=f1ec10012136d, content=有没有美国COG的原始共识呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac335553112, createdName=子不语1号, createdTime=Tue Jul 20 19:05:06 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
2022-07-24 1471d48dm72暂无昵称

学习了

36 0
[GetPortalCommentsPageByObjectIdResponse(id=1234452, encodeId=5be91234452ca, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:50:09 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234009, encodeId=9777123400906, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbfd8246369, createdName=ms2000000967583627, createdTime=Fri Jul 22 12:54:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234008, encodeId=b23f1234008ad, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbfd8246369, createdName=ms2000000967583627, createdTime=Fri Jul 22 12:54:25 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009151, encodeId=887a1009151d8, content=怎么获得积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82c15576659, createdName=ms4000001580579190, createdTime=Wed Aug 18 15:37:03 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001213, encodeId=f1ec10012136d, content=有没有美国COG的原始共识呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac335553112, createdName=子不语1号, createdTime=Tue Jul 20 19:05:06 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
2022-07-22 ms2000000967583627

好

0 0
[GetPortalCommentsPageByObjectIdResponse(id=1234452, encodeId=5be91234452ca, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:50:09 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234009, encodeId=9777123400906, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbfd8246369, createdName=ms2000000967583627, createdTime=Fri Jul 22 12:54:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234008, encodeId=b23f1234008ad, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbfd8246369, createdName=ms2000000967583627, createdTime=Fri Jul 22 12:54:25 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009151, encodeId=887a1009151d8, content=怎么获得积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82c15576659, createdName=ms4000001580579190, createdTime=Wed Aug 18 15:37:03 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001213, encodeId=f1ec10012136d, content=有没有美国COG的原始共识呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac335553112, createdName=子不语1号, createdTime=Tue Jul 20 19:05:06 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
2022-07-22 ms2000000967583627

好

29 0
[GetPortalCommentsPageByObjectIdResponse(id=1234452, encodeId=5be91234452ca, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:50:09 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234009, encodeId=9777123400906, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbfd8246369, createdName=ms2000000967583627, createdTime=Fri Jul 22 12:54:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234008, encodeId=b23f1234008ad, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbfd8246369, createdName=ms2000000967583627, createdTime=Fri Jul 22 12:54:25 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009151, encodeId=887a1009151d8, content=怎么获得积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82c15576659, createdName=ms4000001580579190, createdTime=Wed Aug 18 15:37:03 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001213, encodeId=f1ec10012136d, content=有没有美国COG的原始共识呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac335553112, createdName=子不语1号, createdTime=Tue Jul 20 19:05:06 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
2021-08-18 ms4000001580579190

怎么获得积分啊

56 0
[GetPortalCommentsPageByObjectIdResponse(id=1234452, encodeId=5be91234452ca, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:50:09 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234009, encodeId=9777123400906, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbfd8246369, createdName=ms2000000967583627, createdTime=Fri Jul 22 12:54:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234008, encodeId=b23f1234008ad, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbfd8246369, createdName=ms2000000967583627, createdTime=Fri Jul 22 12:54:25 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009151, encodeId=887a1009151d8, content=怎么获得积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82c15576659, createdName=ms4000001580579190, createdTime=Wed Aug 18 15:37:03 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001213, encodeId=f1ec10012136d, content=有没有美国COG的原始共识呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac335553112, createdName=子不语1号, createdTime=Tue Jul 20 19:05:06 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
2021-07-20 子不语1号

有没有美国COG的原始共识呀

47 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

2020 COG共识意见：四肢横纹肌肉瘤的手术治疗

相关指南

拓展阅读

科室

工具

服务